These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 24345756)

  • 1. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GATA2 deficiency].
    Nonoyama S
    Nihon Rinsho; 2014 Oct; 72(10):1861-9. PubMed ID: 25509816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.
    Maciejewski-Duval A; Meuris F; Bignon A; Aknin ML; Balabanian K; Faivre L; Pasquet M; Barlogis V; Fieschi C; Bellanné-Chantelot C; Donadieu J; Schlecht-Louf G; Marin-Esteban V; Bachelerie F
    J Leukoc Biol; 2016 Jun; 99(6):1065-76. PubMed ID: 26710799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation.
    Lübking A; Vosberg S; Konstandin NP; Dufour A; Graf A; Krebs S; Blum H; Weber A; Lenhoff S; Ehinger M; Spiekermann K; Greif PA; Cammenga J
    Leuk Res Rep; 2015; 4(2):72-5. PubMed ID: 26716079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.
    Dickinson RE; Griffin H; Bigley V; Reynard LN; Hussain R; Haniffa M; Lakey JH; Rahman T; Wang XN; McGovern N; Pagan S; Cookson S; McDonald D; Chua I; Wallis J; Cant A; Wright M; Keavney B; Chinnery PF; Loughlin J; Hambleton S; Santibanez-Koref M; Collin M
    Blood; 2011 Sep; 118(10):2656-8. PubMed ID: 21765025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia.
    Holme H; Hossain U; Kirwan M; Walne A; Vulliamy T; Dokal I
    Br J Haematol; 2012 Jul; 158(2):242-248. PubMed ID: 22533337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GATA2 gene mutations: 3 cases].
    Perrard N; Pokeerbux MR; Quesnel B; Duployez N; Fenwarth L; Preudhomme C; Lefèvre G; Baillet C; Launay D; Terriou L
    Rev Med Interne; 2022 Nov; 43(11):677-682. PubMed ID: 36041908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.
    Ishida H; Imai K; Honma K; Tamura S; Imamura T; Ito M; Nonoyama S
    Eur J Pediatr; 2012 Aug; 171(8):1273-6. PubMed ID: 22430350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 finds its macrophage niche.
    Migliaccio AR; Bieker JJ
    Blood; 2011 Sep; 118(10):2647-9. PubMed ID: 21903902
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
    Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
    Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
    Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
    Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Opportunistic Infections in a Woman with GATA2 Mutation.
    Vila A; Dapás JI; Rivero CV; Bocanegra F; Furnari RF; Hsu AP; Holland SM
    Int J Infect Dis; 2017 Jan; 54():89-91. PubMed ID: 27894982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline GATA2 Mutation and Bone Marrow Failure.
    McReynolds LJ; Calvo KR; Holland SM
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of GATA2 deficiency syndrome.
    Calvo KR; Hickstein DD
    Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive NK cells can persist in patients with
    Schlums H; Jung M; Han H; Theorell J; Bigley V; Chiang SC; Allan DS; Davidson-Moncada JK; Dickinson RE; Holmes TD; Hsu AP; Townsley D; Winkler T; Wang W; Aukrust P; Nordøy I; Calvo KR; Holland SM; Collin M; Dunbar CE; Bryceson YT
    Blood; 2017 Apr; 129(14):1927-1939. PubMed ID: 28209719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.